References - Therapeutic Strategies in Cancer Biology and Pathology - page 259

Xinzhou, H., Ning, Y., Ou, W., Xiaodan, L., Fumin, Y., Huitu, L., et al., 2011. RKIP inhibits
the migration and invasion of human prostate cancer PC-3M cells through regulation of
extracellular matrix. Mol. Biol. 45, 921-928.
Xu, B., Niu, X., Zhang, X., Tao, J., Wu, D., Wang, Z., et al., 2011a. miR-143 decreases pros-
tate cancer cells proliferation and migration and enhances their sensitivity to docetaxel
through suppression of KRAS. Mol. Cell Biochem. 350, 207-213.
Xu, C.R., Lee, S., Ho, C., Bommi, P., Huang, S.A., Cheung, S.T., et al., 2009. Bmi1 functions
as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis. Mol.
Cancer Res. 7, 1937-1945.
Xu, H., Fu, J., Ha, S.W., Ju, D., Zheng, J., Li, L., et al., 2012. The CCAAT box-binding tran-
scription factor NF-Y regulates basal expression of human proteasome genes. Biochim.
Biophys. Acta Mol. Cell Res. 1823, 818-825.
Xu, X., Omelchenko, T., Hall, A., 2010. LKB1 tumor suppressor protein regulates actin fila-
ment assembly through Rho and its exchange factor Dbl independently of kinase activity.
BMC Cell Biol. 77, 11.
Xu, Y, Xia, F, Ma, L, Shan, J, Shen, J, Yang, Z, et al., 2011b. MicroRNA-122 sensitizes HCC
cancer cells to adriamycin and vincristine through modulating expression of MDR and
inducing cell cycle arrest. Cancer Lett. 310, 160-169.
Yageta, M, Kuramochi, M, Masuda, M., Fukami, T., Fukuhara, H., Maruyama, T., et al., 2002.
Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung
cancer. Cancer Res. 62, 5129-5133.
Yam, J.W., Ko, F.C., Chan, C.Y., Jin, D.Y., Ng, I.O., 2006. Interaction of deleted in liver can-
cer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 66,
8367-8372.
Yamagata, K., Fujiyama, S., Ito, S., Ueda, T., Murata, T., Naitou, M., et al., 2009. Maturation
of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell. 36, 340-347.
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., et al., 2001.
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing
mice. J. Clin. Invest. 108, 261-268.
Yan, C., Wang, H., Boyd, D.D., 2001. KiSS-1 represses 92-kDa type IV collagenase expres-
sion by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa
Balpha -induced block of p65/p50 nuclear translocation. J. Biol. Chem. 276, 1164-1172.
Yan, G.R., Xu, S.H., Tan, Z.L., Liu, L., He, Q.Y., 2011. Global identification of miR-373-reg-
ulated genes in breast cancer by quantitative proteomics. Proteomics 11, 9912-9920.
Yan, Y.M., Dai, H.Q., Du, Y., Schneider, B., Guo, H., Li, D.P., et al., 2012. Identification of
blapsins A and B as potent small-molecule 14-3-3 inhibitors from the insect Blaps japan-
ensis. Bioorg. Med. Chem. Lett. 22, 4179-4181.
Yang, C.H., Yue, J., Pfeffer, S.R., Handorf, C.R., Pfeffer, L.M., 2011a. MicroRNA miR-21 reg-
ulates the metastatic behavior of B16 melanoma cells. J. Biol. Chem. 286, 39172-39178.
Yang, G., He, W., Cai, M., Luo, F., Kung, H., Guan, X., et al., 2011b. Loss/down-regulation
of tumor suppressor in lung cancer 1 expression is associated with tumor progression
and is a biomarker of poor prognosis in ovarian carcinoma. Int. J. Gynecol. Cancer 21,
486-493.
Yang, H., Jansen, A., Komar, A., Zheng, X., Merrick, W., Costes, S., et al., 2003a. The trans-
formation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding
protein that inhibits translation. Mol. Cell. Biol. 23, 26-37.
Yang, H., Xiang, J., Wang, N., Zhao, Y., Hyman, J., Li, S., et al., 2009a. Converse confor-
mational control of Smoothened activity by structurally related small molecules. J. Biol.
Chem. 284, 20876-20884.